Table 2 |
|||||
| The numerical value and percentage of breast cancer cases and cancer size in different DBG phenotypes of 5,022 patients (6,012 pathological diagnoses) | |||||
| DBGP | Breast cancer | Benign disease | Total | Cancer size | DBGPF†¶ |
| Fya + Fyb+ | 219(29.8%1) ‡ | 517(70.2%) | 736(100%) | 26 ± 9§ | 620(12.3%) |
| Fya + Fyb- | 1698(33.2%)|| | 3420(66.8%) | 5118(100%) | 26 ± 10 | 4262(84.9%) |
| Fya-Fyb+ | 62(45.6%) | 74(54.4%) | 136(100%) | 27 ± 9 | 120(2.4%) |
| Fya-Fyb- | 13(59.1%) | 9(40.9%) | 22(100%) | 29 ± 7 | 20(0.4%) |
| Total | 1992 | 4020 | 6012 | 5022(100%) | |
† DBGPF = DBGP frequency.
‡ Among these 219 breast cancer, 11 were DCIS; one case was a supplementary radical operation.
§ Among these 219 breast cancers, one case supplementary radical operation was excluded from statistics of cancer size because of primary breast cancers had been removed.
|| Among these 1,698 breast cancers, 112 were DCIS, 10 cases were supplementary radical operations and two cases were occult breast cancers.
¶ Among these 1,698 breast cancers, two cases of axillary lymph nodes biopsies were excluded from the statistics regarding cancer size because the presence of occult breast cancer; 10 cases of supplemental radical operations were excluded from the statistics regarding cancer size as the primary breast cancers had already been removed.
Liu et al. BMC Cancer 2012 12:374 doi:10.1186/1471-2407-12-374
